EXOZYMES INC. 8-K

What Happened eXoZymes Inc. filed a Form 8-K on May 7, 2026 (Item 8.01) announcing that it has provided an investor presentation dated May 7, 2026 to potential underwriters, offering participants and investors in connection with a proposed public offering of securities. The filing includes the presentation as Exhibit 99.1 (Item 9.01).

Key Details

• Filing date: May 7, 2026; disclosure reported under Item 8.01 (Other Events).
• Exhibit included: Exhibit 99.1 — Investor Presentation of eXoZymes Inc. as of May 7, 2026.
• Purpose: Presentation was furnished to potential underwriters and other offering participants and investors for a proposed public offering of securities.
• The 8-K also references the Inline XBRL cover page (Exhibit 104).

Why It Matters This disclosure shows the company is actively preparing for a potential public offering to raise capital and is sharing materials with possible underwriters and investors. For existing and prospective shareholders, that can be an important signal because a public offering may affect share supply and company capitalization — however, the filing does not guarantee an offering will occur or disclose offering terms. Investors should review the investor presentation (Exhibit 99.1) for any material information provided and monitor future filings for details and official offering documents.